The ProcartaPlex Human Coagulation Panel 5plex enables research of wound healing and clotting disorders by analyzing five protein targets in a single well using Luminex xMAP technology.
Type de produit
Multiplex Panel
Quantité
96 Tests
Combinability
Non-Combinable
Type de microbilles
Magnetic
Plage de dosage
See Certificate of Analysis
Marque
Invitrogen
ProcartaPlex preconfigured panels are extensively tested for analyte combinability, interference, and cross-reactivity to provide the highest level of validation and precision. All ProcartaPlex panels are supplied with the necessary reagents to perform the assay.
Target list [bead region]: antithrombin [27], factor XI [29], factor XII [30], factor XIII [47], prothrombin [34]
Points forts
About ProcartaPlex assays for the Luminex platform
ProcartaPlex immunoassays are based on the principles of a sandwich ELISA, using two highly specific antibodies binding to different epitopes of one protein to quantitate all protein targets simultaneously using a Luminex instrument. ProcartaPlex multiplex assays require as little as 25 μL of plasma or serum, or 50 μL of cell culture supernatant, and just four hours to obtain analyzed results.
ProcartaPlex assays utilize Luminex xMAP (multianalyte profiling) technology for the simultaneous detection and quantitation of up to 65 protein targets in a single 25–50 μL sample—from plasma, serum, cell culture supernatants, and other bodily fluids.
Reproducible, reliable results—validated as a panel to the highest industry standard, including protein target combinability and cross-reactivity testing
More results per sample—measure multiple protein targets simultaneously in a single 25–50 μL sample
Well-established Luminex technology—highly referenced multiplexing platform for protein detection and quantitation
